Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.

Cancer chemotherapy and pharmacology

Volumn 57, Issue 1, 2006, Pages 34-39

  Caraglia, Michele ^a   Addeo, Raffaele ^a   Costanzo, Raffaele ^a   Montella, Liliana ^a   Faiola, Vincenzo ^a   Marra, Monica ^a   Abbruzzese, Alberto ^a   Palmieri, Giovannella ^a   Budillon, Alfredo ^a   Grillone, Francesco ^a   Venuta, Salvatore ^a   Tagliaferri, Pierosandro ^a   Del Prete, Salvatore ^a  

^a SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; DOXORUBICIN; DRUG DERIVATIVE; LIPOSOME; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; QUALITY OF LIFE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 33644691816     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0001-z     Document Type: Article

References (0)